Form 8-K Cardiff Oncology, Inc. For: May 19
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Cardiff Oncology sues Nerviano Medical Sciences over license dispute
May 19, 2026 5:03 PM EDTCardiff Oncology Inc. (NASDAQ: CRDF) filed a lawsuit against Nerviano Medical Sciences S.r.L on May 19, 2026, in the United States District Court for the Southern District of California, disputing claims that it materially breached their license agreement for onvansertib.
The complaint seeks... More
